Trials / Completed
CompletedNCT01078220
Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)
A Post-licensure Surveillance Program for the Safety of GARDASIL™ in a Managed Care Organization Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 189,629 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Female
- Age
- 9 Years
- Healthy volunteers
- Accepted
Summary
This is a post-licensure safety surveillance program to detect potential safety signals in subjects, from the managed care organizations database, who have used GARDASIL™.
Conditions
Timeline
- Start date
- 2007-02-06
- Primary completion
- 2010-12-13
- Completion
- 2010-12-13
- First posted
- 2010-03-02
- Last updated
- 2017-07-11
- Results posted
- 2012-01-09
Source: ClinicalTrials.gov record NCT01078220. Inclusion in this directory is not an endorsement.